Global Anti-Venom Market Report History And Forecast 2015-2026

Global Anti-Venom Market Report History And Forecast 2015-2026

Summary

Market Analysis and Insights: Global Anti-Venom Market
The global Anti-Venom market was valued at US$ 891.14 million in 2019 and it is expected to reach US$ 1179.43 million by the end of 2026, growing at a CAGR of 4.17% during 2020-2026.
Global Anti-Venom Scope and Market Size
The global Anti-Venom market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Venom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.

By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm

Segment by Type
Polyvalent Anti-Venom
Monovalent Anti-Venom

Segment by Application
Non-profit Institutions
Hospitals and Clinics
By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
South Korea
India
Southeast Asia
Australia
Europe
Spain
Denmark
Italy
France
Latin America
Brazil
Argentina
Middle East & Africa
Middle East
Africa


1 ANTI-VENOM MARKET OVERVIEW
1.1 Anti-Venom Product Overview
1.2 Anti-Venom Market Segment by Type
1.2.1 Polyvalent Anti-Venom
1.2.2 Monovalent Anti-Venom
1.3 Global Anti-Venom Market Size by Type (2015-2026)
1.3.1 Global Anti-Venom Market Size Overview by Type (2015-2026)
1.3.2 Global Anti-Venom Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global Anti-Venom Sales Market Share Breakdown by Type (2015-2020)
1.3.2.2 Global Anti-Venom Revenue Market Share Breakdown by Type (2015-2020)
1.3.2.3 Global Anti-Venom Average Selling Price (ASP) by Type (2015-2020)
1.3.3 Global Anti-Venom Market Size Forecast by Type (2021-2026)
2 VENOMOUS SNAKEBITES BY REGION
3 GLOBAL ANTI-VENOM MARKET COMPETITION BY COMPANY
3.1 Global Top Players by Anti-Venom Sales (2018-2020)
3.2 Global Top Players by Anti-Venom Revenue (2018-2020)
3.3 Global Top Players by Anti-Venom Average Selling Price (ASP) & (2018-2020)
3.4 Anti-Venom Market Competitive Situation and Trends
3.4.1 Anti-Venom Market Concentration Rate (2018-2020)
3.4.2 Global 5 and 10 Largest Manufacturers by Anti-Venom Sales and Revenue in 2019
3.5 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Venom as of 2019)
3.6 Manufacturing Base Distribution of Key Manufacturers Anti-Venom Market
3.7 Key Manufacturers Anti-Venom Product Offered
3.8 Mergers & Acquisitions, Expansion
4 GLOBAL ANTI-VENOM BY REGION
4.1 Global Anti-Venom Market Size and CAGR by Region: 2015 VS 2020 VS 2026
4.2 Global Anti-Venom Market Size Market Share by Region (2015-2020)
4.2.1 Global Anti-Venom Sales Market Share by Region (2015-2020)
4.2.2 Global Anti-Venom Revenue Market Share by Region (2015-2020)
4.2.3 Global Anti-Venom Sales, Revenue, Price and Gross Margin (2015-2020)
4.3 Global Anti-Venom Market Size Market Share by Region (2021-2026)
4.3.1 Global Anti-Venom Sales Market Share by Region (2021-2026)
4.3.2 Global Anti-Venom Revenue Market Share by Region (2021-2026)
4.3.3 Global Anti-Venom Sales, Revenue, Price and Gross Margin (2021-2026)
5 GLOBAL ANTI-VENOM BY APPLICATION
5.1 Anti-Venom Segment by Application
5.1.1 Non-profit Institutions
5.1.2 Hospitals and Clinics
5.2 Global Anti-Venom Sales by Application: 2015 VS 2020 VS 2026
5.3 Global Anti-Venom Historic Sales by Application (2015-2020)
5.4 Global Anti-Venom Forecasted Sales by Application (2021-2026)
6 NORTH AMERICA ANTI-VENOM MARKET SIZE BY COUNTRY
6.1.1 North America Anti-Venom Sales Market Share by Country (2015-2020)
6.1.2 North America Anti-Venom Revenue Market Share by Country (2015-2020)
7 EUROPE ANTI-VENOM MARKET SIZE BY COUNTRY
7.1.1 Europe Anti-Venom Sales Market Share by Country (2015-2020)
7.1.2 Europe Anti-Venom Revenue Market Share by Country (2015-2020)
8 ASIA-PACIFIC ANTI-VENOM MARKET SIZE BY REGION
8.1.1 Asia-Pacific Anti-Venom Sales Market Share by Region (2015-2020)
8.1.2 Asia-Pacific Anti-Venom Revenue Market Share by Region (2015-2020)
9 LATIN AMERICA ANTI-VENOM MARKET SIZE BY COUNTRY
9.1.1 Latin America Anti-Venom Sales Market Share by Country (2015-2020)
9.1.2 Latin America Anti-Venom Revenue Market Share by Country (2015-2020)
10 MIDDLE EAST AND AFRICA ANTI-VENOM MARKET SIZE BY COUNTRY
10.1.1 Middle East and Africa Anti-Venom Sales Market Share by Country (2015-2020)
10.1.2 Middle East and Africa Anti-Venom Revenue Market Share by Country (2015-2020)
11 COMPANY PROFILES AND KEY FIGURES IN ANTI-VENOM BUSINESS
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Business Overview
11.1.3 CSL Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.1.4 CSL Anti-Venom Products Offered
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Business Overview
11.2.3 Merck Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.2.4 Merck Anti-Venom Products Offered
11.3 BTG
11.3.1 BTG Corporation Information
11.3.2 BTG Business Overview
11.3.3 BTG Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.3.4 BTG Anti-Venom Products Offered
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.4.4 Pfizer Anti-Venom Products Offered
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Bharat Serums and Vaccines Information
11.5.2 Haffkine Bio-Pharmaceutical Business Overview
11.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Products Offered
11.6 Rare Disease Therapeutics
11.6.1 Rare Disease Therapeutics Corporation Information
11.6.2 Rare Disease Therapeutics Business Overview
11.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.6.4 Rare Disease Therapeutics Anti-Venom Products Offered
11.7 Flynn Pharma
11.7.1 Flynn Pharma Corporation Information
11.7.2 Flynn Pharma Business Overview
11.7.3 Flynn Pharma Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.7.4 Flynn Pharma Anti-Venom Products Offered
11.8 Vins Bioproducts
11.8.1 Vins Bioproducts Corporation Information
11.8.2 Vins Bioproducts Business Overview
11.8.3 Vins Bioproducts Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.8.4 Vins Bioproducts Anti-Venom Products Offered
11.9 Bharat Serums and Vaccines
11.9.1 Bharat Serums and Vaccines Corporation Information
11.9.2 Bharat Serums and Vaccines Business Overview
11.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.9.4 Bharat Serums and Vaccines Anti-Venom Products Offered
11.10 Serum Biotech
11.10.1 Serum Biotech Corporation Information
11.10.2 Serum Biotech Business Overview
11.10.3 Serum Biotech Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.10.4 Serum Biotech Anti-Venom Products Offered
11.11 Micropaharm Limited
11.11.1 Micropaharm Limited Corporation Information
11.11.2 Micropaharm Limited Business Overview
11.11.3 Micropaharm Limited Anti-Venom Sales, Revenue and Gross Margin (2018-2020)
11.11.4 Micropaharm Limited Anti-Venom Products Offered
12 ANTI-VENOM UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Anti-Venom Key Raw Materials
12.1.1 Key Raw Materials
12.1.2 Raw Materials Key Suppliers
12.2 Manufacturing Cost Structure
12.2.1 Raw Materials
12.2.2 Labor Cost
12.2.3 Manufacturing Expenses
12.3 Anti-Venom Industrial Chain Analysis
12.4 Market Opportunities, Challenges, Risks, and Influences Factors Analysis
12.4.1 Anti-Venom Market Opportunities and Drivers
12.4.2 Anti-Venom Market Challenges
12.4.3 Porter’s Five Forces Analysis
13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS
13.1 Sales Channel
13.2 Distributors
13.3 Downstream Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
List of Tables and Figures
Table 1. Global Anti-Venom Market Size Growth Potential by Type: CAGR (2020-2026) & (K Vials)
Table 2. Global Anti-Venom Sales by Type (2015-2020) & (K Vials)
Table 3. Global Anti-Venom Sales Share by Type (2015-2020)
Table 4. Global Anti-Venom Revenue (US$ Million) by Type (2015-2020)
Table 5. Global Anti-Venom Revenue Share by Type (2015-2020)
Table 6. Global Anti-Venom Average Selling Price (ASP) & (USD/Vial) by Type (2015-2020)
Table 7. Global Anti-Venom Sales by Type (2021-2026) & (K Vials)
Table 8. Global Anti-Venom Sales Share by Type (2021-2026)
Table 9. Global Venomous Snakebites Comparison by Region in 2019 (in thousands)
Table 10. Global Anti-Venom Sales (K Vials) by Company (2018-2020)
Table 11. Global Anti-Venom Sales Share by Company (2018-2020)
Table 12. Global Anti-Venom Revenue (US$ Million) by Company (2018-2020)
Table 13. Global Anti-Venom Revenue Share by Company (2018-2020)
Table 14. Global Market Anti-Venom Average Selling Price (ASP) & (USD/Vial) by Company (2018-2020)
Table 15. Global Anti-Venom Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Venom as of 2019)
Table 17. Date of Key Manufacturers Enter into Anti-Venom Market
Table 18. Key Manufacturers Anti-Venom Product Type
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Anti-Venom Market Size Comparison by Region (2015-2026) & (US$ Million): 2015 VS 2020 VS 2026
Table 21. Global Anti-Venom Sales (K Vials) by Region (2015-2020)
Table 22. Global Anti-Venom Sales Market Share by Region (2015-2020)
Table 23. Global Anti-Venom Revenue (US$ Million) by Region (2015-2020)
Table 24. Global Anti-Venom Revenue Market Share by Region (2015-2020)
Table 25. Global Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)
Table 26. Global Anti-Venom Sales (K Vials) by Region (2021-2026)
Table 27. Global Anti-Venom Sales Market Share by Region (2021-2026)
Table 28. Global Anti-Venom Revenue (US$ Million) by Region (2021-2026)
Table 29. Global Anti-Venom Revenue Market Share by Region (2021-2026)
Table 30. Global Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2021-2026)
Table 31. Global Anti-Venom Sales (K Vials) by Application: 2015 VS 2020 VS 2026
Table 32. Global Anti-Venom Sales (K Vials) by Application (2015-2020)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook